Pelthos Therapeutics (PTHS) Market Capitalization (2024 - 2026)

Pelthos Therapeutics has reported Market Capitalization for 3 years, with the latest figure at $105.1 million in Q2 2026.

• On a quarterly basis, Market Capitalization rose 1138.69% year-over-year to $105.1 million in Q2 2026; TTM through Jun 2026 was $105.1 million, a 1138.69% increase from a year earlier, with the FY2026 full-year figure at $105.1 million, changed N/A from the prior year.
• Market Capitalization was $105.1 million for Q2 2026 at Pelthos Therapeutics, up from $70.8 million in the prior quarter.
• The five-year high for Market Capitalization was $105.1 million in Q2 2026, with the low at $3.9 million in Q4 2024.
• Average Market Capitalization over 3 years is $36.6 million, with a median of $10.5 million recorded in 2024.
• The largest YoY upside for Market Capitalization was 1994.68% in 2025 against a maximum downside of 28.56% in 2025.
• Over 3 years, Market Capitalization stood at $3.9 million in 2024, then surged by 1389.96% to $58.3 million in 2025, then surged by 80.27% to $105.1 million in 2026.
• The last three Market Capitalization figures came in at $105.1 million (Q2 2026), $70.8 million (Q1 2026), and $58.3 million (Q4 2025), per Business Quant data.